Literature DB >> 33475511

Cardiovascular Assessment Tool for Breast Cancer Survivors and Oncology Providers: Usability Study.

Kathryn E Weaver1,2, Heidi D Klepin3, Brian J Wells4,5, Emily V Dressler4, Karen M Winkfield6, Zanetta S Lamar3, Tiffany P Avery3, Nicholas M Pajewski4, W Gregory Hundley7, Aimee Johnson1, Eleanor C Davidson1, Marcelo Lopetegui8, Randi E Foraker9.   

Abstract

BACKGROUND: Cardiovascular health is of increasing concern to breast cancer survivors and their health care providers, as many survivors are more likely to die from cardiovascular disease than cancer. Implementing clinical decision support tools to address cardiovascular risk factor awareness in the oncology setting may enhance survivors' attainment or maintenance of cardiovascular health.
OBJECTIVE: We sought to evaluate survivors' awareness of cardiovascular risk factors and examine the usability of a novel electronic health record enabled cardiovascular health tool from the perspective of both breast cancer survivors and oncology providers.
METHODS: Breast cancer survivors (n=49) recruited from a survivorship clinic interacted with the cardiovascular health tool and completed pre and posttool assessments about cardiovascular health knowledge and perceptions of the tool. Oncologists, physician assistants, and nurse practitioners (n=20) who provide care to survivors also viewed the cardiovascular health tool and completed assessments of perceived usability and acceptability.
RESULTS: Enrolled breast cancer survivors (84% White race, 4% Hispanic ethnicity) had been diagnosed 10.8 years ago (SD 6.0) with American Joint Committee on Cancer stage 0, I, or II (45/49, 92%). Prior to viewing the tool, 65% of survivors (32/49) reported not knowing their level for one or more cardiovascular health factors (range 0-4). On average, only 45% (range 0%-86%) of survivors' known cardiovascular health factors were at an ideal level. More than 50% of survivors had ideal smoking status (45/48, 94%) or blood glucose level (29/45, 64%); meanwhile, less than 50% had ideal blood pressure (12/49, 24%), body mass index (12/49, 24%), cholesterol level (17/35, 49%), diet (7/49, 14%), and physical activity (10/49. 20%). More than 90% of survivors thought the tool was easy to understand (46/47, 98%), improved their understanding (43/47, 91%), and was helpful (45/47, 96%); overall, 94% (44/47 survivors) liked the tool. A majority of survivors (44/47, 94%) thought oncologists should discuss cardiovascular health during survivorship care. Most (12/20, 60%) oncology providers (female: 12/20, 60%; physicians: 14/20, 70%) had been practicing for more than 5 years. Most providers agreed the tool provided useful information (18/20, 90%), would help their effectiveness (18/20, 90%), was easy to use (20/20, 100%), and presented information in a useful format (19/20, 95%); and 85% of providers (17/20) reported they would use the tool most or all of the time when providing survivorship care.
CONCLUSIONS: These usability data demonstrate acceptability of a cardiovascular health clinical decision support tool in oncology practices. Oncology providers and breast cancer survivors would likely value the integration of such apps in survivorship care. By increasing awareness and communication regarding cardiovascular health, electronic health record-enabled tools may improve survivorship care delivery for breast cancer and ultimately patient outcomes. ©Kathryn E Weaver, Heidi D Klepin, Brian J Wells, Emily V Dressler, Karen M Winkfield, Zanetta S Lamar, Tiffany P Avery, Nicholas M Pajewski, W Gregory Hundley, Aimee Johnson, Eleanor C Davidson, Marcelo Lopetegui, Randi E Foraker. Originally published in JMIR Cancer (http://cancer.jmir.org), 21.01.2021.

Entities:  

Keywords:  breast cancer; cancer survivors; cardiovascular diseases; clinical decision support; electronic health records; usability testing

Year:  2021        PMID: 33475511      PMCID: PMC7861995          DOI: 10.2196/18396

Source DB:  PubMed          Journal:  JMIR Cancer        ISSN: 2369-1999


  31 in total

Review 1.  Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond.

Authors:  Donald M Lloyd-Jones; Yuling Hong; Darwin Labarthe; Dariush Mozaffarian; Lawrence J Appel; Linda Van Horn; Kurt Greenlund; Stephen Daniels; Graham Nichol; Gordon F Tomaselli; Donna K Arnett; Gregg C Fonarow; P Michael Ho; Michael S Lauer; Frederick A Masoudi; Rose Marie Robertson; Véronique Roger; Lee H Schwamm; Paul Sorlie; Clyde W Yancy; Wayne D Rosamond
Journal:  Circulation       Date:  2010-01-20       Impact factor: 29.690

2.  Cardiovascular management of cancer patients with chemotherapy-associated left ventricular systolic dysfunction in real-world clinical practice.

Authors:  Michael Ammon; Nisha Arenja; Gregor Leibundgut; Ronny R Buechel; Gabriela M Kuster; Beat A Kaufmann; Otmar Pfister
Journal:  J Card Fail       Date:  2013-09       Impact factor: 5.712

3.  Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.

Authors:  Laxmi S Mehta; Karol E Watson; Ana Barac; Theresa M Beckie; Vera Bittner; Salvador Cruz-Flores; Susan Dent; Lavanya Kondapalli; Bonnie Ky; Tochukwu Okwuosa; Ileana L Piña; Annabelle Santos Volgman
Journal:  Circulation       Date:  2018-02-01       Impact factor: 29.690

Review 4.  Cardiovascular Disease and Cancer: Is There Increasing Overlap?

Authors:  Logan Vincent; Douglas Leedy; Sofia Carolina Masri; Richard K Cheng
Journal:  Curr Oncol Rep       Date:  2019-04-06       Impact factor: 5.075

5.  Weight change and survival after breast cancer in the after breast cancer pooling project.

Authors:  Bette J Caan; Marilyn L Kwan; Xiao Ou Shu; John P Pierce; Ruth E Patterson; Sarah J Nechuta; Elizabeth M Poole; Candyce H Kroenke; Erin K Weltzien; Shirley W Flatt; Charles P Quesenberry; Michelle D Holmes; Wendy Y Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-13       Impact factor: 4.254

Review 6.  Early breast cancer therapy and cardiovascular injury.

Authors:  Lee W Jones; Mark J Haykowsky; Jonas J Swartz; Pamela S Douglas; John R Mackey
Journal:  J Am Coll Cardiol       Date:  2007-09-24       Impact factor: 24.094

7.  Assessment of Life's Simple 7 in the primary care setting: the Stroke Prevention in Healthcare Delivery EnviRonmEnts (SPHERE) study.

Authors:  Randi E Foraker; Abigail B Shoben; Marcelo A Lopetegui; Albert M Lai; Philip R O Payne; Marjorie Kelley; Caryn Roth; Hilary Tindle; Andrew Schreiner; Rebecca D Jackson
Journal:  Contemp Clin Trials       Date:  2014-04-08       Impact factor: 2.226

8.  Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study.

Authors:  Saro H Armenian; Lanfang Xu; Bonnie Ky; Canlan Sun; Leonardo T Farol; Sumanta Kumar Pal; Pamela S Douglas; Smita Bhatia; Chun Chao
Journal:  J Clin Oncol       Date:  2016-02-01       Impact factor: 44.544

9.  Electronic health record-based assessment of cardiovascular health: The stroke prevention in healthcare delivery environments (SPHERE) study.

Authors:  Randi E Foraker; Abigail B Shoben; Marjorie M Kelley; Albert M Lai; Marcelo A Lopetegui; Rebecca D Jackson; Michael A Langan; Philip R O Payne
Journal:  Prev Med Rep       Date:  2016-07-13

Review 10.  Rethinking the role and impact of health information technology: informatics as an interventional discipline.

Authors:  Philip R O Payne; Yves Lussier; Randi E Foraker; Peter J Embi
Journal:  BMC Med Inform Decis Mak       Date:  2016-03-29       Impact factor: 2.796

View more
  2 in total

1.  Analysis of Epidemiological Characteristics of New Cardiovascular Diseases in Cancer Patients with Cardiovascular Disease.

Authors:  Guangchong Zhang; Yiwen Zhang; Wenguan Li
Journal:  J Oncol       Date:  2022-08-31       Impact factor: 4.501

2.  Addressing cancer survivors' cardiovascular health using the automated heart health assessment (AH-HA) EHR tool: Initial protocol and modifications to address COVID-19 challenges.

Authors:  Randi E Foraker; Eleanor C Davidson; Emily V Dressler; Brian J Wells; Simon Craddock Lee; Heidi D Klepin; Karen M Winkfield; W Gregory Hundley; Philip R O Payne; Albert M Lai; Glenn J Lesser; Kathryn E Weaver
Journal:  Contemp Clin Trials Commun       Date:  2021-06-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.